--- title: "\"Hong Kong Stocks\" Hang Seng Index closed up 95 points, pharmaceutical stocks led the rise, CSPC PHARMA surged nearly 14%" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/280756114.md" description: "Hong Kong stocks rose repeatedly, with the Hang Seng Index closing up 95 points at 24,951 points. Pharmaceutical stocks performed strongly, with CSPC PHARMA's share price rising nearly 14%. Several blue-chip companies announced their earnings, with CITIC Limited, Longfor, and Meituan seeing their share prices decline, while China Ping An and China Mobile's share prices increased. The total market turnover was HKD 263.081 billion" datetime: "2026-03-27T08:34:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280756114.md) - [en](https://longbridge.com/en/news/280756114.md) - [zh-HK](https://longbridge.com/zh-HK/news/280756114.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/280756114.md) | [English](https://longbridge.com/en/news/280756114.md) # "Hong Kong Stocks" Hang Seng Index closed up 95 points, pharmaceutical stocks led the rise, CSPC PHARMA surged nearly 14% U.S. President Trump has extended the suspension of attacks on Iranian energy facilities until the 6th of next month, and Hong Kong stocks fluctuated upward. The Hang Seng Index opened down 87 points, initially fell 143 points to a low of 24,712 points, then rose 239 points to a high of 25,095 points, closing up 95 points or 0.4% at 24,951 points; the National Index rose 63 points or 0.8%, closing at 8,453 points; the Hang Seng Tech Index rose 16 points or 0.3%, closing at 4,778 points. The total market turnover for the day was HKD 263.081 billion. Several blue-chip companies announced their earnings. CITIC Limited (00267.HK) reported a 0.9% increase in annual net profit and declared a final dividend, with its stock price falling 0.2%. Longfor Group (00960.HK) reported a 90% drop in annual net profit, with a core loss of 1.7 billion RMB, and its stock price fell 3.7%. Meituan (03690.HK) management forecasted a halving of core local business losses in the first quarter, with its stock price falling 0.9%. SMIC (00981.HK) reported a 9% increase in annual net profit, with its stock price falling 1.2%. China Mobile (00941.HK) reported a 0.9% drop in annual net profit and declared a final dividend, with its stock price rising 0.7%. Haier Smart Home (06690.HK) reported a 4.4% increase in annual net profit and plans to spend 3 to 6 billion RMB to repurchase A shares, with its stock price falling 4.1%. Ping An Insurance (02318.HK) reported a 7% year-on-year increase in annual net profit, with brokers optimistic that its customer service margin (CSM) may turn positive this year, and its stock price rose 2%. CNOOC (00883.HK) reported a 12% drop in annual net profit, with its stock price falling 0.5%. Pharmaceutical stocks generally rose, with CSPC PHARMA (01093.HK) Chairman Cai Dongchen increasing his stake by 49.4 million shares worth HKD 413 million yesterday (26th), and its stock price surged 13.8%. Innovent Biologics (01801.HK) achieved its first annual profit, with its stock price rising 7.7%. China National Pharmaceutical Group (01177.HK) reported a 31% increase in annual basic profit, with its stock price rising 1.2%. 3SBio (01530.HK) and Yiling Pharmaceutical (09606.HK) rose 10.4% and 11%, respectively, while Ascletis Pharma (02096.HK) and Hansoh Pharmaceutical (01276.HK) rose 8% and 7.8%, respectively. Kelun-Biotech (06990.HK), Rongchang (09995.HK), BeiGene (06160.HK), and Junshi Biosciences (01877.HK) rose 6% to 7.1%. Automobile stocks continued to be favored, with BYD (01211.HK) rising 3.7% to HKD 106.5, and Leapmotor's A-series first model A10 launched, priced from 65,800 RMB, with Leapmotor (09863.HK) rising 5.3%. Xiaomi (01810.HK) and Li Auto (02015.HK) rose 1.7% and 1.5%, respectively. Autonomous driving stock Pony.ai (02026.HK) fell 14%, as the company's non-GAAP losses widened last year. Peer WeRide (00800.HK) rose 4.1% Automobile agency Zhongsheng (00881.HK) reported a loss of over RMB 1.67 billion last year, with its stock price rising 8.1%. Lithium stocks Tianqi Lithium (09696.HK) and Ganfeng Lithium (01772.HK) rose 6.1% and 9.3%. Battery stock CATL (03750.HK) rebounded 2.9%. In the consumer demand sector, Mengniu (02319.HK) saw its net profit increase 13.8 times last year, with its stock price rising 5.3%. Haitian Flavoring (03288.HK) reported a net profit increase of 11% for the year, with a final dividend including a special dividend totaling RMB 1.1, and its stock price rose 8.1%. Mao Geping (01318.HK) had a net profit increase of 37% for the year, with its stock price rising 6.7%. Zhenjiu Lidu (06979.HK), WH Group (00288.HK), and Yihai (01579.HK) rose between 3% and 4.2%, Haidilao (06862.HK) rebounded 4.9%, while Mixue (02097.HK) continued to drop 4.9%. Pop Mart (09992.HK) fell 0.7%. Gold stocks turned from decline to rise, with Zhaojin (01818.HK) and China Gold International (02099.HK) rising 3.5% and 2.6%. Shandong Gold (01787.HK) reported a net profit increase of 61% for the year, with its stock price rising 2.4%. Lingbao (03330.HK) had a net profit increase of 121% for the year, with its stock price rising 5.6%. Resource stock Jiangxi Copper (00358.HK) reported a net profit increase of 7% last year, and its controlling shareholder was approved to issue no more than RMB 5 billion in exchangeable bonds, with its stock price falling 1.5%. Aluminum stock Hongqiao (01378.HK) rose 2.1%. Silver stock China Silver (00815.HK) rose 4.5%. In other tech stocks, Tencent (00700.HK) and Alibaba (09988.HK) fell 0.4% and 0.3%, JD.com (09618.HK) rose 0.1%, Baidu (09888.HK) and Bilibili (09626.HK) fell 0.9% and 1.6%, while NetEase (09999.HK) and Kuaishou (01024.HK) rose 0.8% and 1.1%. Dongfang Zhenxuan (01797.HK) rose 4.9%. Chip stock Huahong (01347.HK) reported a net profit decrease of 6%, with its stock price falling 0.4%. Tensyn Smart Chip (09903.HK) fell 5.4%. AI stock Zhipu (02513.HK) fell 2.3%, while Envision Intelligent (03696.HK) rose 13.7%, and MiniMax (00100.HK) rose 0.4%. Cloud Voice (09678.HK) narrowed its annual loss to RMB 327 million, with its stock price falling 8%. In the financial sector, HSBC (00005.HK) closed flat at HKD 134.8, Hong Kong Exchanges and Clearing (00388.HK) fell 0.1%, and AIA (01299.HK) fell 1.6%. The market is concerned about the pressure on PICC (01339.HK) in the fourth quarter last year, with its stock price falling 7.2% ### 相關股票 - [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/zh-HK/quote/512290.CN.md) - [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/zh-HK/quote/588130.CN.md) - [CSPC PHARMA (01093.HK)](https://longbridge.com/zh-HK/quote/01093.HK.md) - [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-HK/quote/516930.CN.md) - [China Universal CNI HK Connect Innovative Drugs Industry ETF (159570.CN)](https://longbridge.com/zh-HK/quote/159570.CN.md) - [Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880.CN)](https://longbridge.com/zh-HK/quote/520880.CN.md) - [Hwabao WP CSI Pharmaceuticals ETF (562050.CN)](https://longbridge.com/zh-HK/quote/562050.CN.md) - [Bosera Hang Seng SCHK Innovative Drug Select ETF (520690.CN)](https://longbridge.com/zh-HK/quote/520690.CN.md) - [Penghua CSI HK Connect Health Care Composite ETF (513700.CN)](https://longbridge.com/zh-HK/quote/513700.CN.md) - [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-HK/quote/159849.CN.md) - [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-HK/quote/159837.CN.md) - [GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.CN)](https://longbridge.com/zh-HK/quote/513120.CN.md) - [Harvest CNI Communication ETF (159695.CN)](https://longbridge.com/zh-HK/quote/159695.CN.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-HK/quote/516500.CN.md) - [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-HK/quote/510660.CN.md) - [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-HK/quote/512010.CN.md) - [Bosera Hang Seng Health Care ETF(QDII) (513060.CN)](https://longbridge.com/zh-HK/quote/513060.CN.md) - [E Fund Hang Seng SCHK Innovative Drug ETF (159316.CN)](https://longbridge.com/zh-HK/quote/159316.CN.md) - [Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII) (520500.CN)](https://longbridge.com/zh-HK/quote/520500.CN.md) - [Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF (159506.CN)](https://longbridge.com/zh-HK/quote/159506.CN.md) - [ChinaAMC Hang Seng Biotechnology Technology ETF(QDII) (159892.CN)](https://longbridge.com/zh-HK/quote/159892.CN.md) ## 相關資訊與研究 - [CSPC Profit Slips but Dividend Rises as China Pharma Shifts to Innovation](https://longbridge.com/zh-HK/news/280418974.md) - [Grand Pharmaceutical Lifts Revenue, Boosts Innovative Mix Amid Margin Pressure](https://longbridge.com/zh-HK/news/280678162.md) - [CSPC Wins China Approval for New Aprepitant Injection to Strengthen Antiemetic Portfolio](https://longbridge.com/zh-HK/news/280149874.md) - [Hansoh Pharmaceutical says HS-20152 injection receives clinical trial approval from NMPA](https://longbridge.com/zh-HK/news/280077880.md) - [Hansoh pharmaceutical says Xinyue (inebilizumab injection) granted NMPA approval for new indication](https://longbridge.com/zh-HK/news/280820343.md)